Your browser doesn't support javascript.
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters.
Abdelnabi, Rana; Foo, Caroline S; Zhang, Xin; Lemmens, Viktor; Maes, Piet; Slechten, Bram; Raymenants, Joren; André, Emmanuel; Weynand, Birgit; Dallmeier, Kai; Neyts, Johan.
  • Abdelnabi R; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000, Leuven, Belgium.
  • Foo CS; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000, Leuven, Belgium.
  • Zhang X; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000, Leuven, Belgium.
  • Lemmens V; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000, Leuven, Belgium; Molecular Vaccinology and Vaccine Discovery, Leuven, Belgium.
  • Maes P; Laboratory of Clinical and Epidemiological Virology, Rega Institute, KU Leuven, Department of Microbiology, Immunology and Transplantation, 3000, Leuven, Belgium; Zoonotic Infectious Diseases Unit, Leuven, Belgium.
  • Slechten B; Department of Laboratory Medicine, UZ Leuven Hospital, 3000, Leuven, Belgium.
  • Raymenants J; Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000, Leuven, Belgium.
  • André E; Department of Laboratory Medicine, UZ Leuven Hospital, 3000, Leuven, Belgium; Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000, Leuven, Belgium.
  • Weynand B; KU Leuven Department of Imaging and Pathology, Translational Cell and Tissue Research, Division of Translational Cell and Tissue Research, B-3000, Leuven, Belgium.
  • Dallmeier K; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000, Leuven, Belgium; Molecular Vaccinology and Vaccine Discovery, Leuven, Belgium; Global Virus Network, GVN, Leuven, Belgium.
  • Neyts J; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, B-3000, Leuven, Belgium; Molecular Vaccinology and Vaccine Discovery, Leuven, Belgium; Global Virus Network, GVN, Leuven, Belgium. Electronic address: j
Antiviral Res ; 198: 105253, 2022 02.
Article in English | MEDLINE | ID: covidwho-1654044
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
The emergence of SARS-CoV-2 variants of concern (VoCs) has exacerbated the COVID-19 pandemic. End of November 2021, a new SARS-CoV-2 variant namely the omicron (B.1.1.529) emerged. Since this omicron variant is heavily mutated in the spike protein, WHO classified this variant as the 5th variant of concern (VoC). We previously demonstrated that the ancestral strain and the other SARS-CoV-2 VoCs replicate efficiently in and cause a COVID19-like pathology in Syrian hamsters. We here wanted to explore the infectivity of the omicron variant in comparison to the ancestral D614G strain in the hamster model. Strikingly, in hamsters that had been infected with the omicron variant, a 3 log10 lower viral RNA load was detected in the lungs as compared to animals infected with D614G and no infectious virus was detectable in this organ. Moreover, histopathological examination of the lungs from omicron-infected hamsters revealed no signs of peri-bronchial inflammation or bronchopneumonia.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Disease Models, Animal / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study Topics: Variants Limits: Animals / Humans Language: English Journal: Antiviral Res Year: 2022 Document Type: Article Affiliation country: J.ANTIVIRAL.2022.105253

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Disease Models, Animal / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study Topics: Variants Limits: Animals / Humans Language: English Journal: Antiviral Res Year: 2022 Document Type: Article Affiliation country: J.ANTIVIRAL.2022.105253